However, in cardiac-specific ATRAP transgenic mice, the development of cardiac hypertrophy, activation of p38 MAPK, and expression of hypertrophy-related genes in response to chronic Ang II infusion were suppressed, in spite of there being no significant difference in blood pressure between the transgenic mice and wildtype mice. Here, AGT is linked to cardiac hypertrophy.